|
Tuesday 17th October 2023 |
Text too small? |
The a2 Milk Company Limited (a2MC, the Company) refers to its market announcement made on Monday, 18 September confirming that it had provided Synlait Milk Limited (Synlait) with written notice cancelling the exclusive manufacturing and supply rights held by Synlait in respect of stages 1 to 3 of a2MC’s current infant milk formula (IMF) products (being a2 Platinum® and a2 至初®) for sale by a2MC in the markets of China, Australia and New Zealand.
Synlait disputed the notice and, in accordance with the dispute resolution provisions of the manufacturing and supply agreement, a2MC and Synlait entered into a 20-business day period of good faith negotiations, which has not resolved the dispute. The matter will now be submitted to confidential binding arbitration as provided for under the dispute resolution provisions of the manufacturing and supply agreement.
Dispute submitted to arbitration
No comments yet
CHI - NZD/AUD FX rate for HY26 dividend
SEK - Seeka Increases Forecast Full Year Earnings Guidance
ATM - 2026 Annual Meeting - Closing Date for Director Nominations
IFT - Data centre demand drives growth and guidance increase
BGP - Half Year Results to 26 July 2026
September 16th Morning Report
DOW - Retirement of Non-executive Director
FWL - Foley Wines Limited (FWL) Director Retirement
MEL - Meridian Energy monthly operating report for August 2026
BIT - Net Asset Values as at 11 September 2026